Donald Trump and his administration clarified it today that the country will not join a global effort to develop, manufacture and distribute equitably Coronavirus Vaccines.
As World Health Organisation (WHO) is involved, US involvement in the health diplomacy can shape the structure of the Pandemic and its recovery.
Reportedly 170 countries are willing to participate together in fighting the Pandemic together, as they joined hands in Covid19 Vaccines Global Access (Covax) facility.
This collaboration and cooperation which aims to speed up Vaccines production and distribution, securing medicines and sending it to the most covid affected part of the World population.
It was the plan which was cooperatively led by WHO, the Coalition for Epidemic Preparedness Innovations and Gavi. This vaccine alliance was much of a interest to some members of the Trump administration.
This project was backed and supported by traditional U.S. Allies which includes Japan, Germany and the European Commission.
But the result for now is US President and White House will not work with WHO. President Trump has also criticised over which he characterised it as “China-centric” response to the Pandemic.
“The US will continue to engage our international partners to ensure we defeat this virus, but we will not be constrained by multilateral organizations influenced by the corrupt WHO and China,” said Judd Deere, a spokesman for the White House. https://t.co/ckcS00VpCD
— Rob Crilly (@robcrilly) September 1, 2020
White House Spokesperson Judd Deere said, “The United States will continue to engage our international partners to ensure we defeat this virus, but we will not be constrained by multilateral organizations influenced by the corrupt World Health Organization and China.”
“America is taking a huge gamble by taking a go-it-alone strategy,” said Lawrence Gostin, a professor of global health law at Georgetown University.
Experts said, “The U.S. move will also shape what happens elsewhere. The idea behind Covax is to discourage hoarding and focus on vaccinating high-risk people in every country first, a strategy that could lead to better health outcomes and lower costs.”
Read the full Analysis Report by Pew Research Center